Written Question·Department of Health and Social Care·UIN 12664
Prostate Cancer: Drugs
Tabled: 4 November 2024
Answered: 12 November 2024
Question
Chris Ward
Labour — Brighton Kemptown and Peacehaven
To ask the Secretary of State for Health and Social Care, what progress he has made on the development of a clinical policy relating to the use of abiraterone acetate as a first-line treatment for men with locally advanced high-risk prostate cancer; and w
Answer
Karin SmythNHS England has developed a policy proposal for abiraterone acetate and prednisolone to be used as a routine commissioning treatment option for high-risk, hormone sensitive, non-metastatic prostate cancer.In line with NHS England’s service development pro...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 12664) →